FF:0000500: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{F5terms
|id=FF:0000500
|name=J2E erythroblastic leukemia line 30min after treatment with erythropoietin
|namespace=FANTOM5
|def=
|xref=
|is_a=EFO:0001746;;FF:0000337;;...") |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{F5terms | {{F5terms | ||
| | |alt_id= | ||
|comment= | |comment= | ||
|created_by= | |created_by= | ||
| | |def= | ||
|derives_from= | |derives_from= | ||
|develops_from= | |develops_from= | ||
|disjoint_from= | |||
|has_quality= | |has_quality= | ||
|id=FF:0000500 | |||
|is_a=EFO:0001746 ;;FF:0000337 ;;FF:0000346 ;;FF:0000350 ;;FF:0000403 | |||
|is_obsolete= | |||
|located_in= | |located_in= | ||
|name=mouse J2E erythroblastic leukemia line 30min after treatment with erythropoietin sample | |||
|namespace=FANTOM5 | |||
|obo_creation_date= | |||
|part_of= | |part_of= | ||
|preceded_by= | |||
|property_value= | |property_value= | ||
| | |subset= | ||
| | |synonym= | ||
|union_of= | |||
|xref= | |||
}} | }} | ||
Latest revision as of 16:56, 12 September 2014
outline
- id: FF:0000500
- name: mouse J2E erythroblastic leukemia line 30min after treatment with erythropoietin sample
- namespace: FANTOM5
- CAGEd oPOSSUM: NA
Ontology association
Parents
| is_a: | EFO:0001746(development or differentiation design),FF:0000337(erythropoietin treatment sample),FF:0000346(30 minutes sample),FF:0000350(experimentally modified sample),FF:0000403(mouse J2E erythroblastic leukemia cell line sample) |
|---|
Children
| is a: | FF:13065-139I5 (J2E erythroblastic leukemia response to erythropoietin),FF:13131-140G8 (J2E erythroblastic leukemia response to erythropoietin, 00hr30min, biol_rep2),FF:13197-141F2 (J2E erythroblastic leukemia response to erythropoietin) |
|---|
FF Samples
Mouse
- 13065-139I5 (J2E erythroblastic leukemia response to erythropoietin)
- 13131-140G8 (J2E erythroblastic leukemia response to erythropoietin, 00hr30min, biol_rep2)
- 13197-141F2 (J2E erythroblastic leukemia response to erythropoietin)
